Anthony with Yahoo Finance

True investors look ahead, and they don’t panic with day-to-day gyrations of the stock. There is certainly potential for this to be $1 billion baby blockbuster, this is no secret. Big Pharma is starting to poke around the edges, keep following the big money as this is likely to be a buyout candidate over the next 12 to 18 months. The commercialization of the assets can be best accomplished with deeper pockets, although the company has really made some great strides to help push things ahead in the coming months.
 








True investors look ahead, and they don’t panic with day-to-day gyrations of the stock. There is certainly potential for this to be $1 billion baby blockbuster, this is no secret. Big Pharma is starting to poke around the edges, keep following the big money as this is likely to be a buyout candidate over the next 12 to 18 months. The commercialization of the assets can be best accomplished with deeper pockets, although the company has really made some great strides to help push things ahead in the coming months.
iIt seems like a buyout is eminent, do you think the company will position itself as such or do you see it playing out with positive earning surprises over the next year? I’m thinking more of the latter, but who knows.
 




iIt seems like a buyout is eminent, do you think the company will position itself as such or do you see it playing out with positive earning surprises over the next year? I’m thinking more of the latter, but who knows.

Very doubtful Anthony. I encourage you to come spend a day in the field with the reps. You can see first hand what doctors say about BA and what the staff think also. You'll see first hand what we're up against also with this management team. Stop listening to that dope on your Yahoo board who says he's a doctor. Do your research Anthony!
 




True investors look ahead, and they don’t panic with day-to-day gyrations of the stock. There is certainly potential for this to be $1 billion baby blockbuster, this is no secret. Big Pharma is starting to poke around the edges, keep following the big money as this is likely to be a buyout candidate over the next 12 to 18 months. The commercialization of the assets can be best accomplished with deeper pockets, although the company has really made some great strides to help push things ahead in the coming months.
There is a ton of KOL support now with Attia being a very loud and prominent voice now leading the charge. All systems go, back up the truck!
 












True investors look ahead, and they don’t panic with day-to-day gyrations of the stock. There is certainly potential for this to be $1 billion baby blockbuster, this is no secret. Big Pharma is starting to poke around the edges, keep following the big money as this is likely to be a buyout candidate over the next 12 to 18 months. The commercialization of the assets can be best accomplished with deeper pockets, although the company has really made some great strides to help push things ahead in the coming months.

Delusional garbage.
Poking around. The Scientific Hires, Highly Tenured Customer Facing Team and now Lipid Trained Experts have been " Poking Around " since launch. Look where this has got us.
Great strides ? Good golly. The Scientific can't walk and chew gum or sell BA.
Buyout candidate. Hold on Big Fellow. More like Bankrupt candidate.
True investors have been screwed here.
 




iIt seems like a buyout is eminent, do you think the company will position itself as such or do you see it playing out with positive earning surprises over the next year? I’m thinking more of the latter, but who knows.

Buyout is not eminent or imminent, Esperion will soon be back in delisting territory.
 




Delusional garbage.
Poking around. The Scientific Hires, Highly Tenured Customer Facing Team and now Lipid Trained Experts have been " Poking Around " since launch. Look where this has got us.
Great strides ? Good golly. The Scientific can't walk and chew gum or sell BA.
Buyout candidate. Hold on Big Fellow. More like Bankrupt candidate.
True investors have been screwed here.
Oh, Karens.
 




Delusional garbage.
Poking around. The Scientific Hires, Highly Tenured Customer Facing Team and now Lipid Trained Experts have been " Poking Around " since launch. Look where this has got us.
Great strides ? Good golly. The Scientific can't walk and chew gum or sell BA.
Buyout candidate. Hold on Big Fellow. More like Bankrupt candidate.
True investors have been screwed here.


Spot on! Excuses,corrupt management, and an inept field sales.
 




Just keep flipping your nickels Anthony. Your the only one on the planet that thinks this will be a blockbuster. Its been over 3 years now and hardly anyone is on this. If it was the wonder drug that you keep referring too it would already do a billion a year. Your morally corrupt for spouting your nonsense on the yahoo Finance Espr board. Glad to see people putting you in your place in that forum.
 




Looks like a back and fill pattern is developing as the stock works its way higher. The best part of this is the way volume is responding, building a solid base for the next advance forward.
 












Look for a gap up as we approach the next earnings date, near term momentum is resting and gearing up for the next run forward. The stock is behaving well and seems poised for growth.
 




Look for a gap up as we approach the next earnings date, near term momentum is resting and gearing up for the next run forward. The stock is behaving well and seems poised for growth.

Are you talking about gardening or growth of a substandard pharma company with a failed drug? Or is near term momentum a pregnancy term? What a piece of work!
 












Anthony is chatting up hard on Yahoo Finance ESPR board. He never stops with his propaganda on how Esperion is on the verge of making billions with a buyout. Nobody and I mean NOBODY will buy Esperion with its debt load and marginal pitiful sales. How much h is Esperion paying Anthony?